DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Anthem Biosciences Limited — Press Release

NSE 5 hrs ago·21 Jul 2026, 11:19 am

Anthem Biosciences

Anthem Biosciences has announced its unaudited financial results for the quarter ended June 30, 2026. The company has submitted this information to the stock exchange as part of its routine regulatory disclosure process.

For investors, this update is a key milestone for tracking the company's short-term operational performance. It provides an early look at revenue trends and profitability, helping the market assess the company's current business momentum.

Investors should focus on the specific figures within the release, particularly revenue growth and profit margins. Monitoring the company's commentary on future outlooks will be crucial to understanding the trajectory of its business strategy.